Could aspirin help reduce Alzheimer’s-related amyloid plaques?

Written by Sharon Salt, Editor

According to scientists at Rush University Medical Center (IL, USA), a low-dose regimen of aspirin may reduce Alzheimer’s-related amyloid plaques in the brain – indicating a potential new role for this medication. The researchers believe that this could reduce Alzheimer’s disease (AD) pathology and protect memory. Aspirin is one of the most widely used over-the-counter medications in the world, and works by activating PPARα to upregulate TFEB and increase lysosomal biogenesis in brain cells. TFEB is known as a master regulator of lysosomal biogenesis. In the study, which was recently published in The Journal of Neuroscience, the researchers administered aspirin...

To view the full article, please register now for access

It's completely free